Design and evaluation in vitro of controlled release mucoadhesive tablets containing chlorhexidine

Drug Development and Industrial Pharmacy

Volumn 32, Issue 1, 2006, Pages 53-61

  Ceschel, Gian Carlo ^a   Bergamante, Valentina ^a   Calabrese, Valeria ^a   Biserni, Stefano ^a   Ronchi, Celestino ^b   Fini, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MonteResearch   (Italy)

Author keywords

Buccal chlorhexidine controlled release; Carbopol; Local action permeation; Methocel; Mucoadhesive tablets

Indexed keywords

CARBOMER; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; CORSODYL GEL; EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE;

ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; APPARATUS; ARTICLE; CHEEK MUCOSA; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; GEL; IN VITRO STUDY; MALE; MODULATION; MOUTH CAVITY; NONHUMAN; TABLET;

ADHESIVENESS; CHLORHEXIDINE; DELAYED-ACTION PREPARATIONS; MOUTH MUCOSA; PERMEABILITY; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 32344451989     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500388300     Document Type: Article

References (22)

1. Anlar, S., Çapan, Y., Güven, O., Gögüs, A., Dalkara, T., & Hincal, A. A. (1994). Formulation and in vitro-in vivo evaluation of buccoadhesive morphine sulfate tablets. Pharm. Res., 11, 231-236.
2. Audus, K. L., Tavakoli-Saberi, M. R., Zheng, H., & Boyce, E. N. (1992). Chlorhexidine effects on membrane lipid domains of human buccal epithelial cells. J. Dental Res., 71, 1298-1303.
3. Bowden, G. H. (1996). Mutant streptococci caries and chlorhexidine. J. Can. Dental Ass., 62, 703-707.
4. Ceschel, G. C., Maffei, P., Lombardi Borgia, S., & Ronchi, C. (2001). Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Deliv, 8, 161-171.
5. Ceschel, G. C., Maffei, P., & Lombardi Borgia, S. (2001). Design and evaluation of a new mucoadhesive bi-layered tablet containing nimesulide for buccal administration. STP Pharma, 11, 151-156.
6. Ceschel, G. C., Maffei, P., Moretti, M. D. L., Demontis, S., & Peana, A. T. (2000). In vitro permeation through porcine buccal mucosa of salvia desoleana atzei and picci essential oil from topical formulations. Int. J. Pharm., 195, 171-177.
7. Darwazeh, A. M., Lamey, P. J., MacFarlane, T. W., & McCuish, A. C. (1994). The effect of exposure to chlorhexidine gluconate in vitro and in vivo on in vitro adhesion of Candida abicans to buccal epithelial cells from diabetic and non-diabetic subjects. J. Oral Pathol. Med., 23, 130-132.
8. Emilson, C. G. (1994). Potential efficacy of chlorhexidine against mutans streptococci and human dental caries. J. Dental Res., 73, 682-691.
9. Franz, T. J. (1975). Percutaneous absorption: On the relevance on in vitro data. - J. Invest. Dermatol, 64, 190-196.
10. Friend, D. R. (1992). In vitro skin permeation techniques. - J Control. Rel, 18, 235-248.
11. Greenstein, G., & Polson, A. (1998). The role of local drug delivery in the management of periodontal diseases: a comprehensive review. J. Periodontol., 69, 507-520.
12. Lafforgue, C., Carnet, L., Falson, F., Reverdy, M. E., & Freney, J. (1997). Percutaneous absorption of a chlorhexidine digluconate solution. Int. J. Pharm., 147, 243-246.
13. Lboutounne, H., Chaulet, J. F., Ploton, C., Falson, F., & Pirot, F. (2002). Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(e-caprolactone) nanocapsule encapsulated form and as a digluconate. J. Control. Rel., 82, 319-334.
14. Maffei, P., Lombardi Borgia, S., Sforzini, A., Yasin, A., Ronchi, C., & Ceschel, G. C. (2004). Design and in vitro-in vivo evaluation of bi-layered tablet containg benzocaine for local buccal administration. J. Drug Del. Sci. Tech., 14, 363-372.
15. 2+ induced lipid peroxidation and mitochondrial permeability transition. Toxicology Letters, 151, 407-416.
16. Richter, T., & Keipert. (2004). In vitro permeation studies comparing bovine nasal mucosa, porcine cornea and artificial membrane: androstenedione in microemulsions and their components. Eur J Pharm Sci, 58, 137-143.
17. Ritger, P. L., & Peppas, N. A. (1987). A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Rel., 5, 37-42.
18. Salem, A. M., Adams, D., Newman, H. N., & Rawle, L. W. (1987). Anti-microbial properties of two aliphatic amines and chlorhexidine in vitro and in saliva. J. Clin. Periodontol., 14, 44-47.
19. Sköld, K., Twetman, S., Hallgren, A., Yucel-Lindberg, T., & Modéer, T. (1998). Effect of a chlorhexidine/thymol-containing varnish on prostaglandin E2 levels in gingival cervicular fluid. Eur. J. Oral Sci., 106, 571-575.
20. Taylan, B., Çapan, Y., Güven, O., Kes, S., Dalkara, T., & Hincal, A. A. (1996). Design and evaluation of sustained released and buccal adhesive propranolol hydrochloride tablets. J. Contr. Rel., 38, 11-20.
21. Vilches, A. P., Jimenez-Kairuz, A., Alovero, F., Olivera, M. E., Allemandi, D. A., & Manzo, R. H. (2002). Release kinetics and up-take studies of model Fuoroquinolones from carbomer hydrogels. Int. J. Pharm., 246, 17-24.
22. Zhang, H., & Robinson, J. R. (1996). In vitro methods for measuring permeability of the oral mucosa. In Oral mucosal drug delivery, M.J., Rathbone, Ed.; Marcel Dekker, Inc.: New York, 90-93.